An overestimation of cancer-specific mortality was found for women with first estrogen receptor–negative breast cancers and received chemotherapy (absolute difference = 4.54%, 95% CI = 4.27% to 4.86%; relative ratio = 1.26, 95% CI = 1.24 to 1.28) (Table 2). The gene discussed is ESR1; the disease is cancer.